NEU 2.97% $20.45 neuren pharmaceuticals limited

The fact that Neuren are announcing this confirms that they...

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    The fact that Neuren are announcing this confirms that they appreciate that the Acadia bad press has hurt perceptions of the Neuren deal.

    Great news for Acadia and Neuren. This puts a complete lid on the negative press and provides surety that Nuplazid is here to stay. This secures Acaida as a financially secure partner for Neuren to bring Trofinetide through to market.

    Let's see what the market thinks!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.45
Change
0.590(2.97%)
Mkt cap ! $2.583B
Open High Low Value Volume
$20.00 $20.49 $19.94 $2.668M 132.1K

Buyers (Bids)

No. Vol. Price($)
7 166 $20.43
 

Sellers (Offers)

Price($) Vol. No.
$20.45 9 2
View Market Depth
Last trade - 12.00pm 12/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.